Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in IBD
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and...
IBDENC ENC
- Jan 8, 2022
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continuesPeyrin-Biroul
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues Peyrin-Biroulet L, Sandborn WJ, Panaccione R,...
IBDENC ENC
- Jan 8, 2022
COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated
COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation Lev-Tzion R, Focht...
IBDENC ENC
- Jan 8, 2022
Adherence to mediterranean diet in patients with inflammatory bowel disease
Adherence to mediterranean diet in patients with inflammatory bowel disease Fiorindi C, Dinu M, Gavazzi E, Scaringi S, Ficari F, Nannoni...
IBDENC ENC
- Jan 6, 2022
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero Flanagan E, Prentice R, Wright EK,...
IBDENC ENC
- Jan 4, 2022
Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in IBD
Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease D'Haens G, Rieder F,...
IBDENC ENC
- Jan 3, 2022
Natural history of inflammatory bowel disease: a comparison between the East and the WestSong EM,
Natural history of inflammatory bowel disease: a comparison between the East and the West Song EM, Yang SK. Published Dec 2021, in the...
IBDENC ENC
- Jan 2, 2022
Vedolizumab or Tumor Necrosis Factor Antagonist
Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With...
IBDENC ENC
- Jan 1, 2022
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis Nielsen OH, Gubatan JM,...
bottom of page